Michaela Barbier

409 total citations
13 papers, 291 citations indexed

About

Michaela Barbier is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michaela Barbier has authored 13 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 3 papers in Oncology. Recurrent topics in Michaela Barbier's work include Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Treatment and Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Michaela Barbier is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Treatment and Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Michaela Barbier collaborates with scholars based in Switzerland, United States and United Kingdom. Michaela Barbier's co-authors include Philippe Ferber, Joseph L. Izzo, Yves Allemann, Matthias Schwenkglenks, John M. Flack, David A. Calhoun, Patrick Brunel, Robert Hilkert, Milo A. Puhan and Yuki Tomonaga and has published in prestigious journals such as PLoS ONE, Annals of Oncology and PharmacoEconomics.

In The Last Decade

Michaela Barbier

13 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Barbier Switzerland 9 150 97 66 56 50 13 291
Ji-Hung Wang Taiwan 12 190 1.3× 34 0.4× 44 0.7× 36 0.6× 20 0.4× 14 337
Chao Zhu China 11 41 0.3× 97 1.0× 29 0.4× 64 1.1× 31 0.6× 32 341
Jeremy Man Ho Hui China 10 131 0.9× 67 0.7× 98 1.5× 30 0.5× 28 0.6× 26 269
Vijay Chopra India 11 338 2.3× 57 0.6× 113 1.7× 110 2.0× 14 0.3× 39 527
Nikheel S. Kolatkar United States 11 98 0.7× 31 0.3× 139 2.1× 70 1.3× 21 0.4× 17 407
Rosa Coppolecchia United States 3 382 2.5× 39 0.4× 79 1.2× 183 3.3× 15 0.3× 5 525
Zongtao Yin China 13 227 1.5× 65 0.7× 17 0.3× 44 0.8× 20 0.4× 30 395
Jonathan A. Batty United Kingdom 13 223 1.5× 92 0.9× 17 0.3× 129 2.3× 14 0.3× 25 417
Ying Hao China 13 35 0.2× 46 0.5× 49 0.7× 87 1.6× 24 0.5× 28 290
Sara Lightowlers United Kingdom 6 121 0.8× 17 0.2× 44 0.7× 52 0.9× 32 0.6× 16 238

Countries citing papers authored by Michaela Barbier

Since Specialization
Citations

This map shows the geographic impact of Michaela Barbier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Barbier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Barbier more than expected).

Fields of papers citing papers by Michaela Barbier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Barbier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Barbier. The network helps show where Michaela Barbier may publish in the future.

Co-authorship network of co-authors of Michaela Barbier

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Barbier. A scholar is included among the top collaborators of Michaela Barbier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Barbier. Michaela Barbier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lupatsch, Judith E., Michael Mark, Michaela Barbier, et al.. (2025). A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland. Swiss Medical Weekly. 155(1). 3777–3777. 1 indexed citations
2.
Weir, Kristie Rebecca, Sofía C. Zambrano, Katharina Tabea Jungo, et al.. (2025). Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients. Basic & Clinical Pharmacology & Toxicology. 137(3). e70091–e70091. 1 indexed citations
3.
4.
Barbier, Michaela, Yuki Tomonaga, Dominik Menges, et al.. (2022). Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer. PLoS ONE. 17(11). e0277282–e0277282. 8 indexed citations
5.
Menges, Dominik, Henock G. Yebyo, Sarah R. Haile, et al.. (2022). Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment. European Urology Oncology. 5(6). 605–616. 50 indexed citations
6.
Stoffel, Sandro, et al.. (2022). Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study – outcomes, adherence, and costs. Zeitschrift für Gastroenterologie. 60(5). 761–778. 8 indexed citations
7.
Barbier, Michaela, et al.. (2021). Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland. The European Journal of Health Economics. 23(5). 837–846. 13 indexed citations
8.
9.
10.
Panje, Cédric, Judith E. Lupatsch, Michaela Barbier, et al.. (2020). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of Oncology. 31(4). 501–506. 19 indexed citations
11.
12.
13.
Brookman, L, et al.. (2007). Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma. Current Medical Research and Opinion. 23(12). 3113–3122. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji-Hung Wang Breakdown of academic impact, for papers by Chao Zhu Breakdown of academic impact, for papers by Jeremy Man Ho Hui Breakdown of academic impact, for papers by Vijay Chopra Breakdown of academic impact, for papers by Nikheel S. Kolatkar Breakdown of academic impact, for papers by Rosa Coppolecchia Breakdown of academic impact, for papers by Zongtao Yin Breakdown of academic impact, for papers by Jonathan A. Batty Breakdown of academic impact, for papers by Ying Hao Breakdown of academic impact, for papers by Sara Lightowlers
Rankless by CCL
2026